Australian Institute of Health and Welfare (2022) Dementia in Australia, AIHW, Australian Government, accessed 26 September 2022.
Australian Institute of Health and Welfare. (2022). Dementia in Australia. Retrieved from https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Dementia in Australia. Australian Institute of Health and Welfare, 16 September 2022, https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Australian Institute of Health and Welfare. Dementia in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2022 Sep. 26]. Available from: https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Australian Institute of Health and Welfare (AIHW) 2022, Dementia in Australia, viewed 26 September 2022, https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Get citations as an Endnote file:
PDF | 13.3Mb
Dementia is a term used to describe a group of conditions characterised by gradual impairment of brain function, which may impact memory, speech, cognition (thought), personality, behaviour, and mobility.
There are many forms of dementia, the most common being Alzheimer’s disease – a degenerative brain disease caused by nerve cell death resulting in shrinkage of the brain. It is also common for an individual to have multiple types of dementia, known as ‘mixed dementia’. While the likelihood of developing dementia increases with age, dementia is not an inevitable or normal part of the ageing process. Dementia can also develop in people under 65, referred to as younger onset dementia, and in children, which is known as childhood dementia.
Dementia is a significant and growing health and aged care issue in Australia that has a substantial impact on the health and quality of life of people with the condition, as well as their family and friends. As the condition progresses, the functional ability of an individual with dementia declines, eventually resulting in the reliance on care providers in all aspects of daily living. There is currently no cure for dementia but there are strategies that can assist in maintaining independence and quality of life for as long as possible.
Data on this page are taken from chapters of the Dementia in Australia report, which provide detailed, up-to-date statistics and information on dementia.
In 2021, it was estimated that there were between 386,200 (AIHW estimate) and 472,000 Australians living with dementia (Dementia Australia 2020a). Based on AIHW estimates, this is equivalent to 15 people with dementia per 1,000 Australians, which increases to 83 people with dementia per 1,000 Australians aged 65 and over. Nearly two-thirds of Australians with dementia are women.
With an ageing and growing population, it is predicted that the number of Australians with dementia will more than double by 2058 – from 386,200 in 2021 to 849,300 in 2058 (533,800 women and 315,500 men) (Figure 1).
This figure shows the estimated and projected prevalence of dementia by sex between 2010 and 2058. In 2010, the estimated prevalence of dementia across all ages was almost 300,000 persons and it is projected to increase to almost 850,000 persons by 2058. In 2022, it is estimated that almost 400,000 people in Australia have dementia. The estimated number of men with dementia increases from almost 100,000 in 2010 to over 300,000 in 2058. The estimated number of women with dementia increases from almost 200,000 in 2010 to over 500,000 in 2058.
The exact number of people with dementia in Australia (the ‘prevalence’) is currently not known. Estimates vary because there is no single authoritative data source for deriving dementia prevalence in Australia and different approaches are used to generate estimates. For more information, see What is being done to improve dementia prevalence estimates in Australia?
In 2021, the Organisation for Economic Co-operation and Development (OECD) estimated that the prevalence of dementia in Australia was 15.1 cases per 1,000 population, close to the OECD average of 15.7 per 1,000 population and ranking 19th lowest out of 38 countries (OECD 2021).
See Prevalence of dementia for data by age, sex, geographic and socioeconomic area.
A range of factors are known to contribute to the risk of developing dementia and may affect the progression of symptoms. Some risk factors can’t be changed, such as age, genetics and family history. However, several are modifiable, and can be altered to prevent or delay dementia.
High levels of education, physical activity and social engagement are all protective against developing dementia, while obesity, smoking, high blood pressure, hearing loss, depression and diabetes are all linked to an increased risk of developing dementia (Livingston et al. 2017).
See What puts someone at risk of developing dementia? for more information about risk factors.
In 2020, dementia was the second leading cause of death in Australia, accounting for 14,500 deaths (or 9.6% of all deaths). Dementia was the leading cause of death for women and the second leading cause for men, after coronary heart disease.
The number of deaths due to dementia increased from 9,200 deaths in 2010 to 14,500 deaths in 2020. The age-standardised rate, which accounts for differences in the age and sex structure of a population, rose between 2010 and 2020, from 35 to 38 deaths per 100,000 Australians (Figure 2).
For more information, see Deaths due to dementia.
This figure shows the number and age-specific rates of deaths due to dementia for men, women and persons in 2020. The age-specific rates follow a similar pattern for both men and women, overall increasing by age, with women typically having higher rates than men. The age-specific rate of deaths due to dementia for all persons aged 95+ was 4,435 per 100,000 persons.
People with pre-existing chronic conditions, such as dementia, have a greater risk of developing severe illness from COVID-19. Fatal COVID-19 outbreaks have involved many people with dementia. Pre-existing chronic conditions were reported on death certificates for just under 5,400 deaths due to COVID-19, registered by 30 June 2022 in Australia. Of these deaths, 31% had dementia (including Alzheimer’s disease) recorded (ABS 2022). COVID-19 was an associated cause of death for a further 234 deaths due to Dementia including Alzheimer’s disease.
The indirect effects of COVID-19 on people with dementia – including reduced uptake of preventative healthcare services leading to delayed diagnoses, as well as spikes in mental illness, such as loneliness and depression – are not well understood but are thought to be substantial.
See Impact of COVID-19 on deaths among people with dementia for more information, and Dementia deaths during the COVID-19 pandemic in Australia for a detailed assessment of the impact of the first 10 months of the COVID-19 pandemic on dementia mortality rates.
Burden of disease refers to the quantified impact of living with and dying prematurely from a disease or injury and is measured using disability-adjusted life years (DALY). One DALY is equivalent to one year of healthy life lost.
Dementia was the third leading cause of burden of disease in Australia in 2018, behind coronary heart disease and back pain. However, it was the leading cause of burden for women as well as for Australians aged 75 and over. The total burden of dementia was just under 198,000 DALY, with 56% of burden attributable to dying prematurely and 44% from the impacts of living with dementia (Figure 3).
This figure shows the top 10 causes of disease burden by age and sex. In 2018, dementia was the 3rd leading cause of burden for all persons, behind coronary heart disease and back pain and problems. Dementia was the leading cause of burden of disease for women, as well as for all persons in age groups 80-84, 85-89, 90-94 and 95-99.
Around 43% of the overall dementia burden in 2018 could have been avoided if exposure to 6 lifestyle risk factors (overweight including obesity, physical inactivity, tobacco smoking, high blood pressure in midlife, high blood plasma glucose levels, and impaired kidney function) were reduced.
See Burden of disease due to dementia for detailed information on burden attributable to specific risk factors.
Services provided by general practitioners (GPs) and other medical specialists are crucial in diagnosing and managing dementia. If a GP suspects dementia, they typically refer the patient to a qualified specialist, such as a geriatrician, or to a memory clinic for a comprehensive assessment (Dementia Australia 2020b).
There is no single conclusive test available to diagnose dementia, and obtaining a diagnosis often involves a combination of comprehensive cognitive and medical assessments.
Identifying the type of dementia at the time of diagnosis is important to ensure access to appropriate treatment and services. However, there are many forms of dementia with symptoms in common, often making diagnosis a lengthy and complex process involving multiple health professionals (see How is dementia diagnosed?).
Data on GP and specialist services across Australia are a major enduring gap for dementia monitoring. However, recent advancements in data linkage have enabled the examination of these services – see GP and specialist services overview.
In 2016–17, about half (49%) of all services claimed under the Medicare Benefits Schedule (MBS) by people with dementia were for GP consultations, with an average of 20 GP consultations per year, per person with dementia.
Consultations with medical specialists, other than GPs, accounted for 12% of all MBS services used by people with dementia. On average, a person with dementia had 5 specialist services in 2016–17.
The types of specialist services used varied by age, with psychiatrists and neurologists most frequent among people with younger onset dementia (aged under 65), and specialists treating age-related conditions, such as geriatricians and ophthalmologists, increasing in frequency with age.
For more information about patterns of health service use among people with younger onset dementia see Younger onset dementia: new insights using linked data.
Although there is no cure for dementia, there are 4 medicines, subsidised through the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme, that may alleviate some of the symptoms of Alzheimer’s disease.
In 2019–20, there were over 623,000 prescriptions dispensed for dementia-specific medications to just under 64,600 Australians with dementia aged 30 and over. There was a 43% increase in scripts dispensed for dementia-specific medications between 2012–13 and 2019–20.
People with dementia may experience changed behaviours, such as aggression, agitation and delusions, commonly known as behavioural and psychological symptoms of dementia. Non-pharmacological interventions are recommended to manage these symptoms, but antipsychotic medicines may be prescribed as a last resort.
In 2019–20, antipsychotic medications were dispensed to about one-fifth (21%) of the 64,600 people who had scripts dispensed for dementia-specific medication.
For information on medicine types, see Prescriptions for dementia-specific medications.
In 2020–21, there were more than 11.8 million hospitalisations in Australia (AIHW 2022). Of these, dementia was the main reason for admission for about 25,500 hospitalisations, which is equivalent to 2 out of every 1,000 hospitalisations.
For people with dementia, the average length of stay was almost 5 times as long as the average for all hospitalisations (13 days and 2.6 days, respectively). Of the hospitalisations due to dementia, 62% of patients were aged 75–89 (Figure 4).
This figure shows the number of hospitalisations due to dementia, rate of hospitalisations, number of bed days and average length of stay, grouped by age and sex, in 2020-21. The number of hospitalisations for both men and women increased with age up to 85-89, then decreased in the oldest age groups. People with younger onset dementia (aged under 65) had a greater average length of stay (22 days) than older people.
Data presented in this section refer to hospitalisations due to dementia, that is, when dementia was recorded as the principal diagnosis. However, understanding hospitalisations with dementia, that is, all hospitalisations with a record of dementia, whether as the principal and/or additional diagnosis, also provides important insights into the wide-ranging conditions that can lead people living with dementia to use hospital services.
See Hospital care for information on hospitalisations with dementia, as well as data by state, and by dementia type.
Aged care services are an important resource for both people with dementia and their carers. Services include those provided in the community for people living at home (home support and home care), and residential aged care services for those requiring permanent care or short-term respite stays.
Among people with dementia in Australia, 1 in 3 people live in cared accommodation. In 2019–20, there were over 244,000 people living in permanent residential aged care, and more than half (54% or about 132,000) of these people had dementia.
See Aged care and support services used by people with dementia for detailed information on the services and initiatives available.
The My Aged Care system coordinates access to a range of government-subsidised services for older Australians who require care and assistance. After an initial screening, an aged care assessment is completed to establish an individual’s needs and types of services that may help.
People with dementia accounted for 9.7% of all aged care assessments in 2019–20, with over 41,000 people with dementia completing an assessment. Among these 41,000 assessments, 3 in 4 were a comprehensive assessment, which are for people with complex and multiple care needs.
Australia’s response to dementia requires economic investment across health, aged care and welfare sectors. It is estimated that almost $3.0 billion of health and aged care spending in 2018–19 was directly attributable to the diagnosis, treatment and care of people with dementia.
Residential aged care services accounted for the largest share of expenditure (56% or $1.7 billion), followed by community-based aged care services (20% or $596 million) and hospital services (13% or $383 million) (Figure 5).
This figure shows how the $3 billion dollars of dementia expenditure was divided across 8 broad health and aged care service areas. The area with the highest spending, almost $1.7 billion, was residential aged care services followed by almost $600 million on community based aged care services and over $380 million on hospital services.
For detailed information of spending on aged care, health, hospital and support services, see Health and aged care expenditure on dementia.
The level of care required for people with dementia depends upon individual circumstances, but likely increases as dementia progresses. Carers are often family members or friends of people with dementia who provide ongoing, informal assistance with daily activities.
The AIHW estimates that in 2021 there were between 134,900 and 337,200 informal primary carers of people with dementia. Among primary carers of people with dementia, 3 in 4 were female and 1 in 2 were caring for their partner with dementia.
Caring can be a rewarding role with 38% of primary carers of people with dementia reporting feeling closer to the care recipient.
Caring can also be physically, mentally, emotionally, and economically demanding. According to the Australian Bureau of Statistics (ABS) Survey of Disability, Ageing and Carers (SDAC) 2018, among carers of people with dementia:
Further findings from this survey can be found in Carers and care needs of people with dementia.
Australia’s dementia statistics are derived from a variety of sources including administrative data, survey data and epidemiological studies. As each data source has incomplete coverage of people with dementia, it is difficult to accurately report how many Australians are living with dementia. This limits the ability to examine impacts of dementia on individuals with the condition, their carers and support networks, as well as the community and national health and aged care systems more broadly (see Dementia data gaps and opportunities).
Estimating the incidence (new dementia cases in a given period) and prevalence (total cases) of dementia in Australia is vital to evaluating the current and future impacts of the condition, as well as for policy and service planning. There are several factors in the diagnostic process that affect our ability to estimate the number of Australians living with dementia, including:
There are ongoing efforts to improve the accuracy of these estimates, such as through the utilisation of data linkage, electronic health records and the development of a national dementia clinical quality registry. See 'Chapter 8 Dementia data in Australia – understanding gaps and opportunities' in Australia’s health 2020: data insights for more information.
Around 1% of all dementia diagnoses in Australia are childhood dementias caused by over 70 rare genetic disorders (Childhood Dementia Initiative 2020). Most cases of childhood dementia are fatal before adulthood (Dementia Support Australia 2021).
There are limited data available on childhood dementia both within Australia and internationally. Increased awareness and research of childhood dementia is needed to improve the quality of life for children with dementia.
Dementia statistics within Australia are largely sourced from hospital, aged care and cause of death data, likely providing a skewed view towards moderate and severe dementia. There are considerable gaps in primary health care data and use of services by people with dementia living in the community. Further, there is a lack of timely data on dementia disease expenditure. Without this information, it is difficult to determine the demand for dementia services and plan for economic costs to health and social systems.
Understanding patient experiences of people with dementia and their carers is important to assess the quality of care within the health and aged care systems. There is a lack of information on these experiences, and improvements are needed to understand these qualitative aspects to improve quality of care and outcomes for those living with dementia.
See Dementia data gaps and opportunities for more information.
There are considerable gaps in national data on carers of people with dementia in Australia. The ABS SDAC 2018 provides the most up-to-date national information on carers. However, this survey is limited to collecting self-reported information from co-resident carers only for people with dementia and, further, likely under-identifies the number of people with dementia (particularly people with mild dementia living in the community). As a result, it is challenging to comprehensively understand how many Australians provide care to people with dementia and what their unmet needs may be.
Australians living with dementia come from diverse backgrounds and have unique and variable needs for services and support. National data on people with dementia in specific population groups are limited and further research is needed.
Among Aboriginal and Torres Strait Islander people, the rate of dementia is estimated to be 3–5 times as high as rates for Australia overall. However, improvements are needed in the representation of Indigenous Australians in key datasets to support better dementia prevalence estimates.
There are also limited data on Indigenous-specific health and aged care services. Improving data in these areas will help to identify how dementia is understood and managed by Indigenous Australians and improve the development of culturally appropriate and effective policies and services.
Due to sampling issues, data on Indigenous carers of people with dementia and/or carers of Indigenous Australians with dementia are not available as part of the ABS SDAC.
For people from culturally and linguistically diverse (CALD) backgrounds, attitudes towards, as well as access to, aged care and support services need to be considered.
Based on the ABS SDAC 2018, 1 in 2 people with dementia who were born in non-English–speaking countries and were living in the community relied upon informal assistance only (compared to 1 in 3 people who were born in English speaking countries). This may reflect a preference for informal care or may be due to challenges in accessing suitable services. Gaps in data limit the understanding of how individual CALD communities may differ in their experiences of disease, attitudes surrounding dementia and carers, and access to and utilisation of services.
As part of the Dementia in Australia report, Dementia in priority groups focuses on numerous population groups of interest that may benefit from a more specific focus within dementia care.
ABS (Australian Bureau of Statistics) (2019) Disability, Ageing and Carers, Australia: Summary of Findings, 2018– Explanatory notes, ABS, Australian Government, accessed 19 January 2022.
ABS (2022) COVID-19 Mortality in Australia: Deaths registered until 30 June 2022, ABS, Australian Government, accessed 29 July 2022.
AIHW (2022) Admitted patient care 2020–21: Australian hospital statistics, AIHW, Australian Government, accessed 14 July 2022.
Childhood Dementia Initiative (2020) Childhood Dementia: the case for urgent action, Childhood Dementia, accessed 19 January 2022.
Dementia Australia (2020a) Dementia statistics, Dementia Australia, accessed 6 February 2020.
Dementia Australia (2020b) Referral options for diagnosis, Dementia Australia, accessed 11 January 2022.
Dementia Support Australia (2022) Childhood Dementia Support, Dementia Support Australia, accessed 19 January 2022.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D et al. (2017) ‘Dementia prevention, intervention, and care’, The Lancet, 390:2673–734, doi:10.1016/S0140-6736(17)31363-6.
OECD (Organisation for Economic Co-operation and Development) (2021) ‘Health at a Glance 2021: OECD Indicators’, OECD Publishing, doi:10.1787/19991312.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.